OR WAIT null SECS
(Pi) Patient interaction®, the clinical trial experts at First Marketing, today announced the introduction of a new profiling tool called Precision Patient Insights.
POMPANO BEACH, Fla., June 16, 2005 - (Pi) Patient interaction, the clinical trial experts at First Marketing, today announced the introduction of a new profiling tool called Precision Patient Insights. (Pi) utilizes this proprietary process, as well as experience in therapeutic areas across all phases of studies - from phase I to phase IV and beyond - to help clinical trial sponsors learn as much as they can about patients with a specific therapeutic condition. These targets represent the most likely prospects for enrollment in a specific clinical trial.
"Precision Patient Insights uses more than just geographic and demographic information," explains First Marketing's president Ron Drenning. "It blends lifestyle and behavior patterns - known as psychographics - to better understand what motivates this specific group of individuals. Through additional overlays, Precision Patient Insights also enhances the patient profile with media preferences for print, radio and broadcast, allowing for better targeting of the patient recruitment media campaign."
The goal is to provide clinical trial sponsors with predictive information based on an analysis of individuals who have self-reported having a given therapeutic condition. Details include socioeconomic/behavioral characteristics such as income, age, occupation, neighborhood surroundings, household composition and lifestyle habits. Precision Patient Insights also links to a large network of consumer research on media behaviors, such as newspaper, radio and television usage. The result is a unique glimpse into the daily lives of the prospective patient.
"The profile creates a more complete picture of the patient recruitment target," adds Drenning. "Our strategic team can then prepare recruitment materials such as posters, brochures and ads that reinforce themes, images and messages that truly motivate response. Likewise, this profile can be applied to patient retention materials that promote compliance. Better targeting means better results, increasing the likelihood that a clinical trial will enroll on time and bring a product to market more quickly and with less expense."
(Pi) will be exhibiting at the Drug Information Association (DIA) 41st Annual Meeting in Washington, D.C., from June 26-30 at booth 1041.
About the Company
(Pi) Patient interaction, the clinical trial experts at First Marketing, have more than 20 years of experience in patient recruitment and retention. Through a full-service approach, they help facilitate, accelerate and enhance the study enrollment and retention process. Services include site analysis, selection and optimization; online ordering system for recruitment and retention materials; informed consent tools; patient-focused market research; and targeted patient recruitment and retention campaigns. First Marketing helps clients from a variety of industries, including healthcare, financial, telecom and travel, maximize customer relationships through education, cross-sell/upsell, loyalty rewards and channel marketing solutions.